Loading data for HQL — first visit, this takes a few seconds.

Abrdn Life Sciences Inves...

NYSE: HQL · 即時價格 · USD
20.96
-0.59 (-2.74%)
收盤價: Aug 28, 2026, 3:59 PM
20.90
-0.29%
盤後: 5:46 PM

股價、關鍵數字和最新消息,都在這一頁。

Abrdn Life Sciences Investors(HQL)股價、分析與資料

-2.74%
買價20.86
市值637.35M
營收 (ttm)1.11M
淨利(ttm)198.17M
0.71
6.46
3.16
n/a
P/B (ttm)1.14
P/S (ttm)574.32
財報日期n/a
賣價21.94
成交量164,111
20 日平均成交量148,972
開盤價21.45
前收盤價21.55
當日區間20.86 - 21.48
52 週範圍13.88 - 22.67
分析師n/a
目標價n/a
股利$2.24 (10.39%)
除息日2026年8月24日

關於 HQL

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture...

IPO 日期 May 1, 1992
員工 n/a
證券交易所 NYSE
股票代號 HQL
完整的公司簡介

財務表現

Abrdn Life Sciences Investors 在 2025 年的營收為 86.39M,較前一年的 86.69M 減少 -0.35%。 淨利為 85.59M,較前期增加 0.35%。

財務報表
還沒有可用的新聞文章